Practical Management Guide for Clinicians Who Treat Patients with Amiodarone

American Journal of Medicine

Volumn 129, Issue 5, 2016, Pages 468-475

  Epstein, Andrew E ^a   Olshansky, Brian ^b   Naccarelli, Gerald V ^c   Kennedy, John I ^d,e   Murphy, Elizabeth J ^f,g   Goldschlager, Nora ^f,g  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b North Iowa Mercy   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d University of Alabama at Birmingham   (United States)

^e BIRMINGHAM VA MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Adverse drug reactions; Amiodarone; Atrial fibrillation; Ventricular fibrillation; Ventricular tachycardia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ATRIAL FIBRILLATION; FOLLOW UP; GASTROINTESTINAL TOXICITY; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HISTORY; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LIVER TOXICITY; LUNG TOXICITY; NEUROTOXICITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; THYROID FUNCTION; ARRHYTHMIAS, CARDIAC;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; HUMANS;

EID: 84975742248     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2015.08.039     Document Type: Review

References (64)

1. P. Zimetbaum Antiarrhythmic drug therapy for atrial fibrillation Circulation 125 2 2012 381 389
2. A.M. Desai, T.M. Cavanaugh, V.C. Desai, and et al. Trends in the outpatient treatment of atrial fibrillation in the USA from 2001 to 2010 Pharmacoepidemiol Drug Saf 23 5 2014 539 547
3. S.M. Al-Khatib, N.M. LaPointe, L.H. Curtis, and et al. Outpatient prescribing of antiarrhythmic drugs from 1995 to 2000 Am J Cardiol 91 1 2003 91 94
4. N. Goldschlager, A.E. Epstein, G.V. Naccarelli, and et al. A practical guide for clinicians who treat patients with amiodarone: 2007 Heart Rhythm 4 9 2007 1250 1259
5. H.C. Doval, D.R. Nul, H.O. Grancelli, and et al. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) Lancet 344 8921 1994 493 498
6. S.N. Singh, R.D. Fletcher, S.G. Fisher, and et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure N Engl J Med 333 2 1995 77 82
7. D.G. Julian, A.J. Camm, G. Frangin, and et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators Lancet 349 9053 1997 667 674
8. J.A. Cairns, S.J. Connolly, R. Roberts, and M. Gent Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators Lancet 349 9053 1997 675 682
9. J.J. Garguichevich, J.L. Ramos, A. Gambarte, and et al. Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA) Am Heart J 130 3 Pt 1 1995 494 500
10. I. Sim, K.M. McDonald, P.W. Lavori, and et al. Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death Circulation 96 9 1997 2823 2829
11. J.P. Piccini, J.S. Berger, and C.M. O'Connor Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials Eur Heart J 30 10 2009 1245 1253
12. G.H. Bardy, K.L. Lee, D.B. Mark, and et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 3 2005 225 237
13. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators N Engl J Med 337 22 1997 1576 1583
14. J.J. Heger, E.N. Prystowsky, W.M. Jackman, and et al. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation N Engl J Med 305 10 1981 539 545
15. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators Am J Cardiol 72 3 1993 280 287
16. D.P. Zipes, E.N. Prystowsky, and J.J. Heger Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects J Am Coll Cardiol 3 4 1984 1059 1071
17. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators Lancet 350 9089 1997 1417 1424
18. S.J. Connolly, P. Dorian, R.S. Roberts, and et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial JAMA 295 2 2006 165 171
19. D. Roy, M. Talajic, P. Dorian, and et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators N Engl J Med 342 13 2000 913 920
20. C.T. January, L.S. Wann, J.S. Alpert, and et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society Circulation 130 23 2014 2071 2104
21. S. Chatterjee, P. Sardar, D. Mukherjee, and et al. Timing and route of amiodarone for prevention of postoperative atrial fibrillation after cardiac surgery: a network regression meta-analysis Pacing Clin Electrophysiol 36 8 2013 1017 1023
22. L.B. Mitchell, D.V. Exner, D.G. Wyse, and et al. Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial JAMA 294 24 2005 3093 3100
23. J.M. Field, M.F. Hazinski, M.R. Sayre, and et al. Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Circulation 122 18 Suppl 3 2010 S640 S656
24. P.J. Kudenchuk, L.A. Cobb, M.K. Copass, and et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation N Engl J Med 341 12 1999 871 878
25. P. Dorian, D. Cass, B. Schwartz, and et al. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation N Engl J Med 346 12 2002 884 890
26. M.I. Anastasiou-Nana, J.N. Nanas, S.N. Nanas, and et al. Effects of amiodarone on refractory ventricular fibrillation in acute myocardial infarction: experimental study J Am Coll Cardiol 23 1 1994 253 258
27. T.E. Pazdral, J.H. Burton, T.D. Strout, and J.R. Bradshaw Amiodarone and rural emergency medical services cardiac arrest patients: a cost analysis Prehosp Emerg Care 6 3 2002 291 294
28. H.F. Clemo, M.A. Wood, D.M. Gilligan, and K.A. Ellenbogen Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias Am J Cardiol 81 5 1998 594 598
29. E. Galve, T. Rius, R. Ballester, and et al. Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study J Am Coll Cardiol 27 5 1996 1079 1082
30. V. Tuseth, H.J. Jaatun, and K. Dickstein Amiodarone infusion in the treatment of acute atrial fibrillation or flutter: high versus low dose treatment Heart 91 7 2005 964 965
31. A.J. Camm, A. Capucci, S.H. Hohnloser, and et al. A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation J Am Coll Cardiol 57 3 2011 313 321
32. T. Yagdi, S. Nalbantgil, F. Ayik, and et al. Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting J Thorac Cardiovasc Surg 125 6 2003 1420 1425
33. T. Guarnieri, S. Nolan, S.O. Gottlieb, and et al. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial J Am Coll Cardiol 34 2 1999 343 347
34. E.A. Raeder, P.J. Podrid, and B. Lown Side effects and complications of amiodarone therapy Am Heart J 109 5 Pt 1 1985 975 983
35. J.W. Mason Amiodarone N Engl J Med 316 8 1987 455 466
36. M. Jafari-Fesharaki, and M.M. Scheinman Adverse effects of amiodarone Pacing Clin Electrophysiol 21 1 Pt 1 1998 108 120
37. N.M. Allen LaPointe, D. Dai, L. Thomas, and et al. Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease Am J Cardiol 115 3 2015 316 322
38. P.T. Pollak, T. Bouillon, and S.L. Shafer Population pharmacokinetics of long-term oral amiodarone therapy Clin Pharmacol Ther 67 6 2000 642 652
39. A. Kashima, M. Funahashi, K. Fukumoto, and et al. Pharmacokinetic characteristics of amiodarone in long-term oral therapy in Japanese population Biol Pharm Bull 28 10 2005 1934 1938
40. V.R. Vorperian, T.C. Havighurst, S. Miller, and C.T. January Adverse effects of low dose amiodarone: a meta-analysis J Am Coll Cardiol 30 3 1997 791 798
41. B. Olshansky, M. Sami, A. Rubin, and et al. Use of amiodarone for atrial fibrillation in patients with preexisting pulmonary disease in the AFFIRM study Am J Cardiol 95 3 2005 404 405
42. R.E. Dusman, M.S. Stanton, W.M. Miles, and et al. Clinical features of amiodarone-induced pulmonary toxicity Circulation 82 1 1990 51 59
43. W.J. Martin 2nd, and E.C. Rosenow 3rd Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I) Chest 93 5 1988 1067 1075
44. W.J. Martin 2nd, and E.C. Rosenow 3rd Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part 2) Chest 93 6 1988 1242 1248
45. J.I. Kennedy, J.L. Myers, V.J. Plumb, and J.D. Fulmer Amiodarone pulmonary toxicity. Clinical, radiologic, and pathologic correlations Arch Intern Med 147 1 1987 50 55
46. J.L. Myers, J.I. Kennedy, and V.J. Plumb Amiodarone lung: pathologic findings in clinically toxic patients Hum Pathol 18 4 1987 349 354
47. S.N. Singh, S.G. Fisher, P.C. Deedwania, and et al. Pulmonary effect of amiodarone in patients with heart failure. The Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy (CHF-STAT) Investigators (Veterans Affairs Cooperative Study No. 320) J Am Coll Cardiol 30 2 1997 514 517
48. J.E. Kuhlman, C. Teigen, H. Ren, and et al. Amiodarone pulmonary toxicity: CT findings in symptomatic patients Radiology 177 1 1990 121 125
49. I.C. Gleadhill, R.A. Wise, S.A. Schonfeld, and et al. Serial lung function testing in patients treated with amiodarone: a prospective study Am J Med 86 1 1989 4 10
50. B. Coudert, F. Bailly, J.N. Lombard, F. Andre, and P. Camus Amiodarone pneumonitis. Bronchoalveolar lavage findings in 15 patients and review of the literature Chest 102 4 1992 1005 1012
51. W. Van Mieghem, L. Coolen, I. Malysse, and et al. Amiodarone and the development of ARDS after lung surgery Chest 105 6 1994 1642 1645
52. E. Martino, L. Bartalena, F. Bogazzi, and L.E. Braverman The effects of amiodarone on the thyroid Endocr Rev 22 2 2001 240 254
53. S. Basaria, and D.S. Cooper Amiodarone and the thyroid Am J Med 118 7 2005 706 714
54. M.D. Trip, W. Wiersinga, and T.A. Plomp Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism Am J Med 91 5 1991 507 511
55. L. Bartalena, W.M. Wiersinga, M.L. Tanda, and et al. Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association Clin Endocrinol 61 4 2004 494 502
56. G.H. Daniels Amiodarone-induced thyrotoxicosis J Clin Endocrinol Metab 86 1 2001 3 8
57. E. Roti, R. Minelli, E. Gardini, L. Bianconi, and L.E. Braverman Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid Arch Intern Med 153 7 1993 886 892
58. US National Library of Medicine, National Institute of Diabetes and Digestive and Kidney Diseases. Drug record: amiodarone. Available at: http://livertox.nlm.nih.gov/Amiodarone.htm. Accessed July 4, 2015.
59. S.W. Lai, C.L. Lin, K.F. Liao, and C.Y. Lin Amiodarone use and risk of acute pancreatitis: a population-based case-control study Heart Rhythm 12 1 2015 163 166
60. B. Olshansky Warning: acute pancreatitis is associated with slightly higher current amiodarone use Heart Rhythm 12 1 2015 167 168
61. D.M. Coulter, I.R. Edwards, and R.L. Savage Survey of neurological problems with amiodarone in the New Zealand Intensive Medicines Monitoring Programme N Z Med J 103 885 1990 98 100
62. C.F. Orr, and J.E. Ahlskog Frequency, characteristics, and risk factors for amiodarone neurotoxicity Arch Neurol 66 7 2009 865 869
63. J.M. Jacobs, and F.R. Costa-Jussa The pathology of amiodarone neurotoxicity. II. Peripheral neuropathy in man Brain 108 Pt 3 1985 753 769
64. N.E. Anderson, N.M. Lynch, and K.P. O'Brien Disabling neurological complications of amiodarone Aust N Z J Med 15 3 1985 300 304